Search research articles
Contact Us
Filters
Showing results (641-650 of 717) with videos related to
Page
of 72
Sort By:
The Lancet. Oncology
|
November 1, 2024
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
Pier Luigi Zinzani, Koji Izutsu, Neha Mehta-Shah, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
May 9, 2017
Longitudinal relationships among activity in attention redirection neural circuitry and symptom severity in youth
Michele A Bertocci, Genna Bebko, Amanda Dwojak, et al.
Neuroimage. Clinical
|
May 31, 2018
Decreased functional connectivity in the fronto-parietal network in children with mood disorders compared to children with dyslexia during rest: An fMRI study
Tzipi Horowitz-Kraus, Mackenzie Woodburn, Akila Rajagopal, et al.
Molecular Psychiatry
|
February 24, 2016
Predicting clinical outcome from reward circuitry function and white matter structure in behaviorally and emotionally dysregulated youth
M A Bertocci, G Bebko, A Versace, et al.
JAMA Psychiatry
|
February 26, 2015
White matter structure in youth with behavioral and emotional dysregulation disorders: a probabilistic tractographic study
Amelia Versace, Heather Acuff, Michele A Bertocci, et al.
Psychological Medicine
|
January 29, 2014
Behavioral and emotional dysregulation trajectories marked by prefrontal-amygdala function in symptomatic youth
M A Bertocci, G Bebko, T Olino, et al.
Cancer
|
January 30, 2019
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study
Steven I Park, Steven M Horwitz, Francine M Foss, et al.
Cancer
|
December 3, 2016
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States
Kenneth R Carson, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
Stephen M Ansell, Michael B Maris, Alexander M Lesokhin, et al.
The Lancet. Oncology
|
December 1, 2024
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
Swaminathan P Iyer, R Alejandro Sica, P Joy Ho, et al.
Page
of 72
Search research articles
Search
Showing results (641-650 of 717) with videos related to
Sort By:
Page
of 72
The Lancet. Oncology
|
November 1, 2024
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
Pier Luigi Zinzani, Koji Izutsu, Neha Mehta-Shah, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
May 9, 2017
Longitudinal relationships among activity in attention redirection neural circuitry and symptom severity in youth
Michele A Bertocci, Genna Bebko, Amanda Dwojak, et al.
Neuroimage. Clinical
|
May 31, 2018
Decreased functional connectivity in the fronto-parietal network in children with mood disorders compared to children with dyslexia during rest: An fMRI study
Tzipi Horowitz-Kraus, Mackenzie Woodburn, Akila Rajagopal, et al.
Molecular Psychiatry
|
February 24, 2016
Predicting clinical outcome from reward circuitry function and white matter structure in behaviorally and emotionally dysregulated youth
M A Bertocci, G Bebko, A Versace, et al.
JAMA Psychiatry
|
February 26, 2015
White matter structure in youth with behavioral and emotional dysregulation disorders: a probabilistic tractographic study
Amelia Versace, Heather Acuff, Michele A Bertocci, et al.
Psychological Medicine
|
January 29, 2014
Behavioral and emotional dysregulation trajectories marked by prefrontal-amygdala function in symptomatic youth
M A Bertocci, G Bebko, T Olino, et al.
Cancer
|
January 30, 2019
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study
Steven I Park, Steven M Horwitz, Francine M Foss, et al.
Cancer
|
December 3, 2016
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States
Kenneth R Carson, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
Stephen M Ansell, Michael B Maris, Alexander M Lesokhin, et al.
The Lancet. Oncology
|
December 1, 2024
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
Swaminathan P Iyer, R Alejandro Sica, P Joy Ho, et al.
Page
of 72